-

Agilent Wins Trade Secret and Patent Infringement Litigation

J&X Technologies to pay Agilent more than $1.25 million in damages for “willful and malicious” theft of Agilent trade secrets

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The court victory in the Northern District of Texas, Dallas Division, requires J&X to pay Agilent more than $1.25 million for illegally using Agilent patents and trade secrets in developing gas chromatography equipment.

The court victory also prevents J&X and its founders Xiaosheng Guan and Qiang Xu from manufacturing, distributing, or selling products using Agilent proprietary gas chromatography information. In addition, J&X is prohibited from disclosing or using Agilent gas chromatography information or other proprietary information. In its ruling, the Court noted that “J&X’s misappropriation of Agilent’s trade secrets was willful and malicious.”

“This court victory reinforces the critical importance Agilent places on protecting our intellectual property,” said Mike Tang, Agilent senior vice president and general counsel. “Innovation is central to what Agilent is all about and this court decision should stand as a message to those seeking to undermine our focus on innovation. We will always seek to protect our proprietary technology and the hard work of Agilent employees developing it to serve our customers.”

Gas chromatography is an analytical technique used to separate the chemical components of a sample mixture. It is used to detect what is in the mixture and how much of a given element or compound is present. Typical uses of gas chromatography include testing the purity of a particular substance or separating the different components of a mixture to understand how it is constituted.

Agilent has long been a leader in developing gas chromatography equipment. The company welcomes competition on its merits and looks forward to continuing to drive innovation in all areas of its business.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent wins trade secret and patent Infringement ruling; J&X Technologies to pay Agilent more than $1.25 million in damages.
Release Versions
$Cashtags

Contacts

Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

More News From Agilent Technologies Inc.

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit...

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% core(1) compared with the first quarter of 2025. First-quarter GAAP net income was $305 million, or $1.07 per share. This compares with $318 million, or $1.11 per share, in the first quarter of 2025. Non-GAAP(2) net income was $386 million, or $1.36 per share, during the quarter, compared wi...

Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen’s 46th Annual Health Care Conference. The event is scheduled for 11:10 to 11:40 a.m. EST on Tuesday, March 3, 2026, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website. About Agilent Tec...
Back to Newsroom